|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.84 0.00 (0.00%) as of 4:30 Tue 5/25
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
18,810,000 |
| Market
Cap: |
15.71(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.835 - $0.835 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Novan is a pharmaceutical company focused on dermatology and anti-infective therapies. Co. has clinical-stage dermatology and anti-infective drug candidates with multi-factorial (SB204), anti-viral (SB206), anti-fungal (SB208), and anti-inflammatory (SB414) mechanisms of action. Co. has also introduced a possible anti-viral product candidate for the treatment of external genital warts (SB207). Co. has conducted or is conducting preclinical work on new chemical entities, including berdazimer sodium, and formulations for the potential treatment of SARS-CoV-2, the virus that causes COVID-19 (SB019); and antimicrobial indications for the adjacent companion animal health market (NVN4100).
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
11,553 |
11,553 |
| Total Sell Value |
$0 |
$0 |
$4,716 |
$4,716 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
1 |
1 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sanders Machelle |
Director |
– • – |
2023-06-27 |
4 |
S |
$0.41 |
$4,716 |
D/D |
(11,553) |
25,248 |
|
- |
|
| Gay John M. |
Chief Financial Officer |
• – – |
2023-06-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,669) |
46,831 |
|
- |
|
| Gay John M. |
Chief Financial Officer |
• – – |
2023-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
65,000 |
67,500 |
|
- |
|
| Geer W Kent |
Director |
– • – |
2023-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,101 |
37,683 |
|
- |
|
| Keegan Robert J |
Director |
– • – |
2023-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,101 |
42,404 |
|
- |
|
| Sanders Machelle |
Director |
– • – |
2023-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,101 |
36,801 |
|
- |
|
| Skolsky Steven D |
Director |
– • – |
2023-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,101 |
36,101 |
|
- |
|
| Bierman James L |
Director |
– • – |
2023-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,101 |
40,101 |
|
- |
|
| Bierman James L |
Director |
– • – |
2022-04-07 |
4 |
B |
$3.45 |
$3,449 |
D/D |
1,000 |
4,000 |
2.31 |
- |
|
| Bierman James L |
Director |
– • – |
2022-03-28 |
4 |
B |
$3.45 |
$3,450 |
D/D |
1,000 |
3,000 |
2.31 |
- |
|
| Bierman James L |
Director |
– • – |
2022-03-25 |
4 |
B |
$3.55 |
$7,090 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
| Palmour John W |
Director |
– • – |
2022-03-18 |
4 |
B |
$3.64 |
$36,350 |
D/D |
10,000 |
69,356 |
2.39 |
- |
|
| Gay John M. |
Chief Financial Officer |
• – – |
2022-03-18 |
4 |
B |
$3.50 |
$3,500 |
D/D |
1,000 |
2,500 |
2.66 |
- |
|
| Palmour John W |
Director |
– • – |
2022-03-17 |
4 |
B |
$3.34 |
$16,705 |
D/D |
5,000 |
59,356 |
2.39 |
- |
|
| Palmour John W |
Director |
– • – |
2022-03-16 |
4 |
B |
$3.34 |
$16,685 |
D/D |
5,000 |
54,356 |
2.39 |
- |
|
| Stafford Paula B |
President and CEO |
• • – |
2021-03-26 |
4 |
B |
$1.43 |
$100,100 |
D/D |
70,000 |
150,693 |
2.81 |
-42% |
|
| Palmour John W |
Director |
– • – |
2020-03-03 |
4 |
B |
$0.00 |
$0 |
D/D |
200,000 |
493,568 |
2.31 |
35% |
|
| Sanders Machelle |
Director |
– • – |
2020-03-03 |
4 |
B |
$0.00 |
$0 |
D/D |
7,000 |
7,000 |
2.31 |
35% |
|
| Malin Corp Plc |
10% Owner |
– – • |
2019-07-02 |
4 |
S |
$2.75 |
$17,289 |
I/I |
(6,287) |
2,598,485 |
|
- |
|
| Malin Corp Plc |
10% Owner |
– – • |
2019-07-01 |
4 |
S |
$2.74 |
$2,502 |
I/I |
(913) |
2,604,772 |
|
- |
|
| Malin Corp Plc |
10% Owner |
– – • |
2019-06-28 |
4 |
S |
$2.69 |
$47,882 |
I/I |
(17,800) |
2,605,685 |
|
- |
|
| Martin G. Kelly |
Chief Executive Officer |
• • – |
2019-05-29 |
4 |
B |
$1.97 |
$2,955 |
I/I |
1,500 |
45,000 |
2.58 |
- |
|
| Martin G. Kelly |
Chief Executive Officer |
• • – |
2019-05-28 |
4 |
B |
$2.15 |
$7,525 |
I/I |
3,500 |
43,500 |
2.58 |
- |
|
| Palmour John W |
Director |
– • – |
2019-05-24 |
4 |
B |
$2.20 |
$44,000 |
D/D |
20,000 |
293,568 |
2.39 |
- |
|
| Ingram Robert Alexander |
Director |
– • – |
2019-05-22 |
4 |
B |
$2.21 |
$110,500 |
D/D |
50,000 |
169,777 |
2.39 |
- |
|
58 Records found
|
|
Page 1 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
